Harmony Biosciences Holdings, Inc. (HRMY)
39.41
+0.20
(+0.51%)
USD |
NASDAQ |
Aug 31, 16:00
39.41
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Cash from Operations (Annual) : 348.20M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 348.20M |
| December 31, 2024 | 219.82M |
| December 31, 2023 | 219.39M |
| December 31, 2022 | 144.47M |
| Date | Value |
|---|---|
| December 31, 2021 | 98.56M |
| December 31, 2020 | -2.985M |
| December 31, 2019 | -75.44M |
| December 31, 2018 | -38.80M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Liquidia Corp. | -35.69M |
| Repligen Corp. | 117.42M |
| Johnson & Johnson | 24.53B |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| ANI Pharmaceuticals, Inc. | 185.22M |